Cargando…

Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension

IMPORTANCE: Older patients with hypertension receiving intensive systolic blood pressure control (110-130 mm Hg) have lower incidences of cardiovascular events than those receiving standard control (130-150 mm Hg). Nevertheless, the mortality reduction is insignificant, and intensive blood pressure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Chia-Te, Toh, Han Siong, Sun, Li, Yang, Chun-Ting, Hu, Angie, Wei, Dongmei, Melgarejo, Jesus, Zhang, Zhen-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972197/ https://www.ncbi.nlm.nih.gov/pubmed/36848091 http://dx.doi.org/10.1001/jamanetworkopen.2023.0708

Ejemplares similares

Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure–Lowering Therapy
por: Foy, Andrew J., et al.
Publicado: (2021)

Evaluation of Intensive vs Standard Blood Pressure Reduction and Association With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis
por: Dallaire-Théroux, Caroline, et al.
Publicado: (2021)

Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region
por: Liao, Chia-Te, et al.
Publicado: (2021)

Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial
por: Croall, Iain D., et al.
Publicado: (2018)

Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension: A Secondary Analysis of Randomized Clinical Trials
por: Chen, Tao, et al.
Publicado: (2022)

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma
por: Rodday, Angie Mae, et al.
Publicado: (2021)

Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease
por: Johnson, Scott, et al.
Publicado: (2019)

Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial
por: Rashid, Tanweer, et al.
Publicado: (2023)

Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis
por: Lin, Yu-Min, et al.
Publicado: (2022)

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial
por: Rooks, Daniel, et al.
Publicado: (2020)

Effect of 24-h blood pressure dysregulations and reduced ocular perfusion pressure in open-angle glaucoma progression
por: Melgarejo, Jesus D., et al.
Publicado: (2023)

Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial
por: Scarpa, Joseph, et al.
Publicado: (2019)

Cardiac Involvement of COVID-19: A Comprehensive Review
por: Chang, Wei-Ting, et al.
Publicado: (2021)

A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs
por: Yu, Wen-Liang, et al.
Publicado: (2020)

Assessment of Machine Learning vs Standard Prediction Rules for Predicting Hospital Readmissions
por: Morgan, Daniel J., et al.
Publicado: (2019)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Association of Hypertensive Disorders of Pregnancy With Future Cardiovascular Disease
por: Rayes, Bilal, et al.
Publicado: (2023)

Association of Physician Education and Feedback on Hypertension Management With Patient Blood Pressure and Hypertension Control
por: Brunström, Mattias, et al.
Publicado: (2020)

The effect of blood pressure variability on the prognosis of hypertensive patients
por: Taher, Ziad A., et al.
Publicado: (2019)

Estimated Costs Associated With Management of Otosclerosis With Hearing Aids vs Surgery in Europe
por: Bonnafous, Sophie, et al.
Publicado: (2022)

Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial
por: Blumberger, Daniel M., et al.
Publicado: (2022)

Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
por: Melgarejo, Jesus D., et al.
Publicado: (2022)

Comparison of Distal Radius Fracture Outcomes in Older Adults Stratified by Chronologic vs Physiologic Age Managed With Casting vs Surgery
por: Jayaram, Mayank, et al.
Publicado: (2023)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Assessment of Costs of Avoidable Delays in Intensive Care Unit Discharge
por: Bagshaw, Sean M., et al.
Publicado: (2020)

Cost-effectiveness of an Emergency Department–Based Intensive Care Unit
por: Bassin, Benjamin S., et al.
Publicado: (2022)

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
por: Park, Jay J. H., et al.
Publicado: (2022)

Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults
por: Seldon, Crystal, et al.
Publicado: (2021)

Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran
por: Hatam, Nahid, et al.
Publicado: (2016)

Neighborhood Characteristics and Elevated Blood Pressure in Older Adults
por: Sims, Kendra D., et al.
Publicado: (2023)

A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
por: Goh, Siew Wen, et al.
Publicado: (2020)

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2021)

Comparison of Childbirth Delivery Outcomes and Costs of Care Between Women Experiencing vs Not Experiencing Homelessness
por: Yamamoto, Ayae, et al.
Publicado: (2021)

Cost-effectiveness of Intermittent vs Continuous Pulse Oximetry Monitoring in Infants Hospitalized With Stabilized Bronchiolitis
por: Moretti, Myla E., et al.
Publicado: (2022)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Comparative Effectiveness of Intracranial Pressure Monitoring vs No Monitoring in Severe Penetrating Brain Injury Management
por: Mansour, Ali, et al.
Publicado: (2023)

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Li, Xingzhe, et al.
Publicado: (2021)

High-Intensity vs Low-Intensity Knowledge Translation Interventions for Surgeons and Their Association With Process and Outcome Measures Among Patients Undergoing Rectal Cancer Surgery
por: Simunovic, Marko, et al.
Publicado: (2021)

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Youssef, Irini, et al.
Publicado: (2022)

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma
por: Su, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fkdrnjijh71p62gpc4afgv5gh